Stay updated on Nivolumab Combo vs Pemetrexed/Cisplatin in Mesothelioma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Combo vs Pemetrexed/Cisplatin in Mesothelioma Clinical Trial page.

Latest updates to the Nivolumab Combo vs Pemetrexed/Cisplatin in Mesothelioma Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedRevision: v3.4.2 replaces v3.4.1. No observable changes to the study details page or its content.SummaryDifference0.0%

- Check19 days agoChange DetectedRevision: v3.4.1 added; Revision: v3.4.0 removed.SummaryDifference0.0%

- Check27 days agoChange DetectedThe update adds UI/metadata changes: Show glossary, Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0, while removing Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4.SummaryDifference0.1%

- Check41 days agoChange DetectedRevision label updated from v3.3.3 to v3.3.4; this is a minor metadata change and does not affect page content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check62 days agoChange DetectedExpanded the Study Details page to include a broader Locations section with numerous new trial sites across the United States, Australia, and other countries.SummaryDifference2%

- Check91 days agoChange DetectedPublications section wording updated to indicate publications are automatically filled from PubMed, with Revision: v3.3.2 added. The previous text implying that publications come directly from PubMed was removed.SummaryDifference0.1%

Stay in the know with updates to Nivolumab Combo vs Pemetrexed/Cisplatin in Mesothelioma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Combo vs Pemetrexed/Cisplatin in Mesothelioma Clinical Trial page.